July 10 (Reuters) - Context Therapeutics Inc ( CNTX ):
* CONTEXT THERAPEUTICS ACQUIRES PHASE 1-READY T CELL ENGAGER
CT-95
* CONTEXT THERAPEUTICS ( CNTX ) - ACQUISITION EXPANDS CONTEXT
PIPELINE WITH
SECOND CLINICAL-STAGE T CELL ENGAGER FOR SOLID TUMORS
* CONTEXT THERAPEUTICS ( CNTX ) - CT-95 IS ON TRACK FOR PHASE 1
INITIATION
IN Q1 OF 2025
* CONTEXT THERAPEUTICS ( CNTX ): INTEND TO FUND DEAL OF CT-95 AND
ADVANCEMENT THROUGH DOSE ESCALATION PORTION OF PHASE 1 CLINICAL
TRIAL WITH EXISTING CASH
Source text for Eikon:
Further company coverage: